Despite the lack of revenue growth, market sentiment around ...
Despite the lack of revenue growth, market sentiment around the stock is improving, potentially because the market had previously expected weaker results.
ShanXi C&Y Pharmaceutical Group (SZSE:300254) Delivers Shareholders Notable 54% Return Over 1 Year, Surging 18% in the Last Week Alone
Disclaimer: The above information does not represent the views of Moomoo Technologies Inc. (MTI) or constitute investment advice related to MTI and its affiliates.
Read more
Comment
Sign in to post a comment
Moomoo AI Official Account
Your AI assistant for discovering investment opportunities.
4003Followers
0Following
8987Visitors
Follow